Skip to main content
logo
Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
99.60
+1.11 (1.13%)
At close: Oct 9, 2026, 4:00 PM EDT
99.70
+0.10 (0.10%)
After-hours: Oct 9, 2026, 7:59 PM EDT

Abbott Laboratories Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
12,59311,16411,45911,36911,14210,35810,97410,63510,3779,96410,24110,1439,9789,74710,09110,41011,25711,89511,46810,928
Revenue Growth (YoY)
13.02%7.78%4.42%6.90%7.37%3.95%7.16%4.85%4.00%2.23%1.49%-2.56%-11.36%-18.06%-12.01%-4.74%10.11%13.76%7.17%23.44%
Cost of Revenue
5,3254,8904,9135,0754,8544,4684,8804,6984,6034,4634,5004,6054,4834,3314,5344,6294,9334,9874,3094,423
Gross Profit
7,2686,2746,5466,2946,2885,8906,0945,9375,7745,5015,7415,5385,4955,4165,5575,7816,3246,9087,1596,505
Selling, General & Admin
3,8663,5812,9272,9032,9452,9142,7252,7602,7972,8272,5372,6012,6052,6422,7352,6292,6512,6882,9332,699
Research & Development
892767720766725716728713698684578672715654578782684697758672
Amortization of Goodwill & Intangibles
658422422420420420465470471472481496498491496498507512514520
Operating Expenses
5,4164,7704,0694,0894,0904,0503,9183,9433,9663,9833,5963,7693,8183,7873,8093,9093,8423,8974,2053,891
Operating Income
1,8521,5042,4772,2052,1981,8402,1761,9941,8081,5182,1451,7691,6771,6291,7481,8722,4823,0112,9542,614
Interest Expense
-351-174-120-121-121-131-136-142-140-141-159-166-159-153-154-141-132-131-131-133
Interest & Investment Income
521067877718291918280899798101885526141110
Currency Exchange Gain (Loss)
-413151711710116--2410-21-614-19-36-4
Other Non Operating Income (Expenses)
-25--152-9-2018-14-6-21-15-3941-914-9-24-21-46
EBT Excluding Unusual Items
1,5241,4492,4352,1802,1501,7782,1591,9401,7501,4362,0361,6711,6361,5621,7101,7582,3522,8762,8362,493
Merger & Restructuring Charges
---77----129----144----234----509-
Gain (Loss) on Sale of Investments
-----------39----45-----
Gain (Loss) on Sale of Assets
---------143-----------
Asset Writedown
-----------100----111-----
Other Unusual Items
----------42---------
Pretax Income
1,5241,4492,3582,1802,1501,7782,0301,9401,6071,4361,7951,6711,6361,5621,3201,7582,3522,8762,3272,493
Income Tax Expense
596372582536371453-7,199294305211201235261244287323334429338393
Earnings From Continuing Operations
9281,0771,7761,6441,7791,3259,2291,6461,3021,2251,5941,4361,3751,3181,0331,4352,0182,4471,9892,100
Net Income
9281,0771,7761,6441,7791,3259,2291,6461,3021,2251,5941,4361,3751,3181,0331,4352,0182,4471,9892,100
Preferred Dividends & Other Adjustments
--24---2---6511-469988
Net Income to Common
9281,0771,7521,6441,7791,3259,2271,6461,3021,2251,5881,4311,3641,3181,0291,4292,0092,4381,9812,092
Net Income Growth (YoY)
-47.84%-18.72%-81.01%-0.12%36.64%8.16%481.05%15.02%-4.54%-7.06%54.33%0.14%-32.11%-45.94%-48.06%-31.69%69.68%36.58%-7.90%70.64%
Shares Outstanding (Basic)
1,7401,7421,7471,7421,7431,7391,7461,7391,7431,7401,7481,7391,7501,7421,7541,7531,7541,7621,7821,775
Shares Outstanding (Diluted)
1,7431,7471,7471,7491,7511,7471,7461,7481,7511,7501,7481,7481,7501,7521,7541,7641,7651,7741,7821,789
Shares Change (YoY)
-0.45%-0.01%0.06%0.10%-0.02%-0.14%-0.11%-0.04%0.07%-0.12%-0.34%-0.87%-0.88%-1.28%-1.57%-1.42%-1.55%-0.95%-0.39%0.06%
EPS (Basic)
0.530.621.000.941.020.765.280.950.750.700.910.820.780.760.590.821.151.381.111.18
EPS (Diluted)
0.530.611.000.941.010.765.260.940.740.700.910.820.780.750.590.811.141.371.111.17
EPS Growth (YoY)
-47.52%-19.74%-80.95%0%36.49%8.57%479.45%14.63%-5.06%-6.67%55.01%1.23%-31.63%-45.23%-47.23%-30.77%72.73%36.94%-7.54%69.56%

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
1,9919162,6262,2911,5459332,1482,1491,4276272,2831,3176967631,7162,3132,0311,7442,4532,240
Free Cash Flow Per Share
1.140.521.501.310.880.531.231.230.810.361.310.750.400.440.981.311.150.981.381.25
Dividend Per Share
0.6300.6300.6300.5900.5900.5900.5900.5500.5500.5500.5500.5100.5100.5100.5100.4700.4700.4700.4700.450
Dividend Growth (YoY)
6.78%6.78%6.78%7.27%7.27%7.27%7.27%7.84%7.84%7.84%7.84%8.51%8.51%8.51%8.51%4.44%4.44%4.44%4.44%25.00%
Gross Margin
57.72%56.20%57.13%55.36%56.44%56.86%55.53%55.83%55.64%55.21%56.06%54.60%55.07%55.57%55.07%55.53%56.18%58.07%62.43%59.53%
Operating Margin
14.71%13.47%21.62%19.39%19.73%17.76%19.83%18.75%17.42%15.24%20.95%17.44%16.81%16.71%17.32%17.98%22.05%25.31%25.76%23.92%
Profit Margin
7.37%9.65%15.29%14.46%15.97%12.79%84.08%15.48%12.55%12.29%15.51%14.11%13.67%13.52%10.20%13.73%17.85%20.50%17.27%19.14%
Free Cash Flow Margin
15.81%8.21%22.92%20.15%13.87%9.01%19.57%20.21%13.75%6.29%22.29%12.98%6.98%7.83%17.00%22.22%18.04%14.66%21.39%20.50%
EBITDA
2,9122,3073,2692,9962,9752,5962,9832,7952,6132,3232,9582,5932,4772,4352,5552,6873,3043,8343,8373,461
EBITDA Margin
23.12%20.66%28.53%26.35%26.70%25.06%27.18%26.28%25.18%23.31%28.88%25.56%24.82%24.98%25.32%25.81%29.35%32.23%33.46%31.67%
D&A For EBITDA
1,060803792791777756807801805805813824800806807815822823883847
EBIT
1,8521,5042,4772,2052,1981,8402,1761,9941,8081,5182,1451,7691,6771,6291,7481,8722,4823,0112,9542,614
EBIT Margin
14.71%13.47%21.62%19.39%19.73%17.76%19.83%18.75%17.42%15.24%20.95%17.44%16.81%16.71%17.32%17.98%22.05%25.31%25.76%23.92%
Effective Tax Rate
39.11%25.67%24.68%24.59%17.26%25.48%-15.15%18.98%14.69%11.20%14.06%15.95%15.62%21.74%18.37%14.20%14.92%14.52%15.76%
SEC Filings: 10-K · 10-Q